MIT releases FINGERS-7B, open-source AI for early Alzheimer's prediction

MIT released an open-source AI model this week that identifies Alzheimer's risk years before cognitive symptoms appear, with claimed 4× higher accuracy than prior preclinical methods. Weights, training code, and evaluation pipelines are public through the Alzheimer's Disease Data Initiative platform. For people with family history of dementia, for clinicians weighing early-intervention trials, for researchers building on top — this is the first open model trained on the WW-FINGERS network's multinational dataset.

The model is FINGERS-7B, from MIT's Picower Institute for Learning and Memory (lab directed by Li-Huei Tsai). Lead researchers: Arvid Gollwitzer at the Broad Institute and Adrian Noriega, an MIT-Novo Nordisk AI Fellow. The methodological shift is joint multi-modal training — lifestyle records, clinical history, genomic data, and proteomic biomarkers feed one model rather than separate predictors stitched together. Training data comes from the WW-FINGERS network, a 40-country collaboration of ~30,000 participants built on Professor Miia Kivipelto's original FINGER trial, combining clinical/lifestyle records with genomic and proteomic datasets from partnering labs. The model produces three outputs per individual: estimated Alzheimer's risk, projected cognitive decline trajectory, and predicted intervention response — which lifestyle or clinical intervention is likely to help which person. Headline gains: 4× more accurate preclinical diagnosis than prior methods, 130% improvement in responder stratification.

Alzheimer's research has historically been slow to get open-source ML infrastructure that combines population-scale data with full weight transparency. Most prior risk-prediction work used proprietary cohorts or closed model weights — papers you could read but models you couldn't run. FINGERS-7B is deployed in AD Workbench, the Alzheimer's Disease Data Initiative's secure cloud platform, which means researchers can apply the model to their own protected health data without exfiltrating PHI to an external API. The preprint is on OpenReview (id: fVqvRQ6XRV). For the broader pattern of AI-in-health releases, this is closer to the BigBio/MedLM open-data shape than the FDA-approved-black-box shape — and that distinction matters for who can build derivative work without licensing barriers.

This is preprint, not peer-reviewed yet — the 4× and 130% numbers come with the usual caveats: small effect sizes can move headline ratios, baseline methods matter, and validation against future cohorts is the real test. The WW-FINGERS dataset also skews European in its origins; generalization to other populations needs separate work. But for anyone working in biomedical ML, or anyone with a family interest in dementia prevention, this is one of the more concrete recent moves toward early-detection tooling that's usable outside one lab.